IGNACIO
TORRE SALABERRI
Hospital Sierrallana
Torrelavega, EspañaPublicaciones en colaboración con investigadores/as de Hospital Sierrallana (2)
2020
-
Anti-il-6 receptor tocilizumab in refractory graves’ orbitopathy: National multicenter observational study of 48 patients
Journal of Clinical Medicine, Vol. 9, Núm. 9, pp. 1-15
2019
-
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases
Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089